Back to Barclays plc Barclays plc

RMTI

Showing 6 of 10 quarters

Position history for Barclays plcBarclays plc's holdings in Rockwell Medical, Inc.

No. Barclays exited its RMTI (Rockwell Medical) position in Q3 2026. Its Q2 2026 13F listed 209 shares worth $115. Barclays first reported RMTI in Q3 2022 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$89,821

Total Shares Change

-22,625

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%$8.54
0
2026-Q2
New
209
-
$1150.0%$5.50
17
2025-Q2
Exited
0
-100.0%
$00.0%$8.50
0
2025-Q1
Decreased
1,254
-95.7%
$1,4170.0%$11.30
0
2024-Q4
Increased
28,854
+27.5%
$58,8620.0%$20.40
18
2024-Q3
New
22,625
-
$89,8210.0%$39.70
33

Other major holders of RMTI: Vanguard Group Inc., Marshall Wace, LLP, Renaissance Technologies LLC

Optional analytics helps us improve. How it’s used